Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases

Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up

(2011) Geertje M. Bartelds   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trough infliximab concentration may predict long-term maintenance of infliximab in ankylosing spondylitis

(2010) D Chu Miow Lin et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: Results from a randomized control study

(2009) Roman Krzysiek et al.   ARTHRITIS AND RHEUMATISM

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis

(2009) Denis Mulleman et al.   ARTHRITIS RESEARCH & THERAPY

Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial

(2008) Gert Van Assche et al.   GASTROENTEROLOGY

Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis

(2008) Zhenhua Xu et al.   JOURNAL OF CLINICAL PHARMACOLOGY